Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zenith HealthcareBOM:530665 +1.88%63 Days Inventory is 155.93 as of Mar. 2026, which is 38% above its 10-year median of 112.78. GuruFocus rates BOM:530665 with a GF Score™ of 63/100 and a GF Value™ of ₹3.63 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, Zenith Healthcare ranks worse than 56.51% on this metric.
The historical rank and industry rank for Zenith Healthcare's Days Inventory or its related term are showing as below:
BOM:530665'
s Days Inventory Range Over the Past 10 Years
Min: 94.03 Med: 112.78 Max: 195.75
Current: 179.82
During the past 13 years, Zenith Healthcare's highest Days Inventory was 195.75. The lowest was 94.03. And the median was 112.78.
BOM:530665's Days Inventory is ranked worse than 56.51% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs BOM:530665: 179.82
Zenith Healthcare's Days Inventory
increased
from Mar. 2025 (139.10) to Mar. 2026 (155.93).
It might indicate that Zenith Healthcare's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zenith Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.59.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zenith Healthcare's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.12.
Zenith Healthcare (BOM:530665) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zenith Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zenith Healthcare's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zenith Healthcare Days Inventory Related Terms
Zenith Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Zenith Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zenith Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenith Healthcare Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zenith Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zenith Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenith Healthcare (BOM:530665) has a Days Inventory of 155.93 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zenith Healthcare and its competitors. This is 38% above median its historical median of 112.78. Over the past decade, Zenith Healthcare's Days Inventory has ranged from 94.03 to 195.75. According to the industry distribution chart, Zenith Healthcare ranks #521 out of 922 companies in the Drug Manufacturers industry, placing it in the top 56.5%.
Is Zenith Healthcare's Days Inventory too high?
Zenith Healthcare's current Days Inventory of 155.93 is 38% above median its 10-year median of 112.78. Over the past 10 years, this metric has ranged from a low of 94.03 to a high of 195.75. The Drug Manufacturers industry median Days Inventory is 165.01. Zenith Healthcare's value of 155.93 is 5.5% below this industry median. Based on the distribution chart, Zenith Healthcare ranks #521 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zenith Healthcare has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenith Healthcare's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zenith Healthcare ranks #521 out of 922 companies for Days Inventory. This places Zenith Healthcare in the lower half of its industry. The industry median Days Inventory is 165.01. Zenith Healthcare's value of 155.93 is 5.5% below this benchmark. Historically, Zenith Healthcare's own Days Inventory has ranged from 94.03 to 195.75 over the past decade. While the company's 10-year median is 112.78 vs. the industry median of 165.01, Zenith Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenith Healthcare's current Days Inventory of 155.93 is 5.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zenith Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenith Healthcare's current Days Inventory is 155.93, which is 38% above median its own 10-year median of 112.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Zenith Healthcare (BOM:530665) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹3.63, compared to a current price of ₹3.25 — trading 10.5% below its estimated fair value. The current Days Inventory is 155.93, which is 38% above median its 10-year median of 112.78 and 5.5% below the Drug Manufacturers industry median of 165.01. Zenith Healthcare's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zenith Healthcare (BOM:530665), the current Days Inventory is 155.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zenith Healthcare (BOM:530665) Overvalued in 2026?
Based on GuruFocus' analysis, Zenith Healthcare stock appears to be undervalued.
The current stock price of ₹3.25 is trading 10.5% below its estimated GF Value™ of ₹3.63.
GuruFocus considers Zenith Healthcare to be Modestly Undervalued.
Key valuation signals for BOM:530665:
Days Inventory: 155.93 (38% above median its 10-year median of 112.78)
GF Value™: ₹3.63 vs. price of ₹3.25 (10.5% below fair value)
Industry Position: 5.5% below the Drug Manufacturers median (#521 of 922)
No single metric tells the full story. See the BOM:530665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zenith Healthcare Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and trading of pharmaceutical formulations. The company also undertakes contracts for manufacturing business. It manufactures pharmaceutical formulations in the form of Tablets, Capsules, Oral liquids, and injectables. The company sells its products in India and also exports internationally.
63GF Score
Get the complete analysis for BOM:530665
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530665 has been successfully added to your 
